^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    DecisionDx®-SCC

    Company:
    Castle Biosci
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    DecisionDx-SCC, our gene expression profile (GEP) test was designed to identify the risk of metastasis in SCC patients with one or more risk factors, based on the biologic profile of 40 genes within their tumor tissue. DecisionDx-SCC is performed on formalin-fixed, paraffin embedded (FFPE) primary tumor tissue from either a biopsy or excision.
    Cancer:
    Squamous Cell Carcinoma
    Method:
    RT-PCR